Altered α-synuclein homeostasis causing Parkinson's disease: The potential roles of dardarin

Trends in Neurosciences

Volumn 28, Issue 8, 2005, Pages 416-421

  Singleton, Andrew B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ENZYME; HUNTINGTIN; LEUCINE RICH REPEAT KINASE 2; PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; DOPAMINERGIC NERVE CELL; GENE DUPLICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MISSENSE MUTATION; NEUROFILAMENT; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SUBSTANTIA NIGRA; WILD TYPE;

EID: 22144439077     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2005.05.009     Document Type: Article

References (31)

1. M.G. Spillantini α-Synuclein in Lewy bodies Nature 388 1997 839 840
2. M.H. Polymeropoulos Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
3. M. Arrasate Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
4. A.B. Singleton α-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
5. D.W. Miller α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication Neurology 62 2004 1835 1838
6. A. Singleton, and K. Gwinn-Hardy Parkinson's disease and dementia with Lewy bodies: a difference in dose? Lancet 364 2004 1105 1107
7. M.C. Chartier-Harlin α-Synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 2004 1167 1169
8. M. Farrer Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications Ann. Neurol. 55 2004 174 179
9. P. Ibanez Causal relation between α-synuclein gene duplication and familial Parkinson's disease Lancet 364 2004 1169 1171
10. E.K. Tan α-Synuclein haplotypes implicated in risk of Parkinson's disease Neurology 62 2004 128 131
11. P. Spadafora NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy Neurosci. Lett. 351 2003 75 78
12. C. Holzmann Polymorphisms of the α-synuclein promoter: expression analyses and association studies in Parkinson's disease J. Neural Transm. 110 2003 67 76
13. E.K. Tan Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability Neurosci. Lett. 336 2003 70 72
14. I. Mizuta Meta-analysis of α synuclein/NACP polymorphism in Parkinson's disease in Japan J. Neurol. Neurosurg. Psychiatry 73 2002 350
15. N. Khan Parkinson's disease is not associated with the combined α-synuclein/apolipoprotein E susceptibility genotype Ann. Neurol. 49 2001 665 668
16. Y. Izumi Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan Neurosci. Lett. 300 2001 125 127
17. R. Kruger Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype Ann. Neurol. 45 1999 611 617
18. P. Pals α-Synuclein promoter confers susceptibility to Parkinson's disease Ann. Neurol. 56 2004 591 595
19. M. Farrer α-Synuclein gene haplotypes are associated with Parkinson's disease Hum. Mol. Genet. 10 2001 1847 1851
20. C.E. Mamah Interaction of α-synuclein and tau genotypes in Parkinson's disease Ann. Neurol. 57 2005 439 443
21. O. Chiba-Falek, and R.L. Nussbaum Effect of allelic variation at the NACP-Rep1 repeat upstream of the α-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system Hum. Mol. Genet. 10 2001 3101 3109
22. A. Singleton The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases Hum Mol Genet 13 Suppl. 1 2004 R123 R126
23. C. Paisán-Ruiz Cloning of the gene containing mutations that cause PARK8 linked Parkinson disease Neuron 44 2004 595 600
24. A. Zimprich Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
25. W.P. Gilks A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 2005 415 416
26. A. Di Fonzo A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 365 2005 412 415
27. W.C. Nichols Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease Lancet 365 2005 410 412
28. D.G. Hernandez Clinical and positron emission tomography of Parkinson's disease caused by LRRK2 Ann. Neurol. 57 2005 453 456
29. J. Kachergus Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations Am. J. Hum. Genet. 76 2005 672 680
30. Paisán-Ruíz, C. et al. LRRK2 gene in Parkinson's disease: mutation analysis and case control association study. Neurology (in press)
31. Bras, J-M. et al. Mutations in LRRK2 are a common cause of Parkinson's disease in a Portuguese cohort. Mov. Disord. (in press)